CBT-I Clinical Training Manual, Webinar, and Certification
Insomnia, which is highly prevalent in adults as a primary or co-morbid disorder, is significantly more prevalent as a consequence of Covid-19. CBT-I is now considered the first-line treatment for chronic insomnia in adults due to its superior long-term efficacy, lack of side effects, and patient preference. It is also the most efficacious psychological therapy for a health problem. It improves sleep in 70-80% of patients, is more effective than sleeping pills and reduces or eliminates sleeping pills in the vast majority of patients, and doubles the improvement rates of depression compared to antidepressant medication alone in depressed patients with insomnia. It also improves other co-morbidities including pain and fibromyalgia, substance abuse, PTSD, and menopausal hot flashes. As a result, chronic insomnia is now considered an independent disorder that should be treated separately from co-morbid conditions.
Compared to CBT-I, sedative-hypnotics are associated with significant side effects and dangers, including elevated mortality risk, that have resulted in new FDA black box warnings about the potentially fatal side effects of Ambien, Lunesta, and Sonata. As a result of the black box warning, more patients and their physicians will be choosing CBT-I as a safe and more effective treatment option. However, there is a dire shortage of clinicians and sleep clinics with expertise in CBT-I due to a scarcity of training opportunities in this area.
For all clinicians and professionals who see clients or patients and wish to develop expertise in CBT-I, Dr. Gregg D. Jacobs, a behavioral sleep medicine specialist and CBT-I expert, offers a CBT-I clinical training manual (PDF format), a two hour archived webinar that accompanies the manual , and CBT-I certification. This is the only CBT-I manual and webinar currently available that provides a state-of-the-art, empirically validated CBT-I five session protocol and CBT-I certification.